Status:
COMPLETED
'Fix the Dysfunction' Concept for Mechanism-based Pharmacological Treatment of Neuropathic Pain by Drug
Lead Sponsor:
Rambam Health Care Campus
Collaborating Sponsors:
Israel Science Foundation
Conditions:
Neuropathic Pain
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Introduction Treatment of neuropathic pain has been a goal of numerous research projects for the last half century, with overall disappointing results. These poor achievements are in contrast with sub...
Detailed Description
Introduction Treatment of neuropathic pain has been a goal of numerous research projects for the last half century, with overall disappointing results. These poor achievements are in contrast with sub...
Eligibility Criteria
Inclusion
- age of 18-80 yrs,
- both genders, \* non-pregnant or breast feeding,
- free of significant chronic pain syndromes other than the neuropathy,
- free of major neurological or psychiatric disorders such as dementia, psychosis and similar.
Exclusion
- \*communication and language difficulties that hinder their performance in the various tests.
- One-hundred healthy subjects will be recruited, with the same inclusion exclusion criteria.
Key Trial Info
Start Date :
October 19 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03276689
Start Date
October 19 2017
End Date
December 30 2020
Last Update
May 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Medical Center
Haifa, Israel